Response to neoadjuvant trastuzumab and chemotherapy in ER+ and ER- HER2-positive breast cancers: Gene expression analysis.
G. Bianchini
No relevant relationships to disclose
A. Prat
No relevant relationships to disclose
M. Pickl
Employment or Leadership Position - Roche
A. Belousov
Employment or Leadership Position - Roche
A. Koehler
Employment or Leadership Position - Roche
Stock Ownership - Roche
V. Semiglazov
No relevant relationships to disclose
W. Eiermann
No relevant relationships to disclose
S. Tjulandin
Honoraria - AstraZeneca; GlaxoSmithKline; Roche
M. Biakhov
No relevant relationships to disclose
A. Lluch
Honoraria - Roche
Other Remuneration - Roche
M. Zambetti
No relevant relationships to disclose
F. J. Vazquez Mazon
No relevant relationships to disclose
J. Baselga
Consultant or Advisory Role - Roche
L. Gianni
Consultant or Advisory Role - Genentech; GlaxoSmithKline; Novartis; Pfizer; Roche; Wyeth